Shopping Cart
- Remove All
- Your shopping cart is currently empty
Lumicitabine (ALS-008176) is an RSV polymerase inhibitor.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $347 | 7-10 days | |
10 mg | $541 | 7-10 days | |
1 mL x 10 mM (in DMSO) | $329 | 7-10 days |
Description | Lumicitabine (ALS-008176) is an RSV polymerase inhibitor. |
In vivo | In an adult human challenge study, Lumicitabine has shown efficacy against RSV infection[1]. Lumicitabine solubility is adequate to support oral administration in solutions with a relatively low percentage of organic solvent and in aqueous suspensions. High levels of NMP and NTP are obtained following the oral administration of Lumicitabine to monkeys [2]. |
Animal Research | Rats: Lumicitabine is formulated as solutions in PEG400-based vehicles. Pharmacokinetic studies are conducted at 5 mg/kg and for oral PK studies, the prodrugs are administered at 5 mg/kg parent nucleoside equivalent doses. Blood samples are typically collected at various time points up to 24 h post dose for rat [2]. Monkeys: Lumicitabine is formulated as a solution in PEG400-based vehicles. Pharmacokinetic studies are conducted at 5 mg/kg and for oral PK studies, the prodrugs are administered at 5 mg/kg parent nucleoside equivalent doses. Blood samples are typically collected at various time points up to 12 h post dose for Monkeys [2]. |
Alias | ALS-8176, ALS-008176 |
Molecular Weight | 433.86 |
Formula | C18H25ClFN3O6 |
Cas No. | 1445385-02-3 |
Relative Density. | 1.43 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 48 mg/mL (110.63 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.